Coronary calcium score, albuminuria and inflammatory markers in type 2 diabetic patients: Associations and prognostic implications

Diabetes Research and Clinical Practice

Volumn 98, Issue 1, 2012, Pages 98-103

  Dayan, Akin ^a   Narin, Burcu ^a   Biteker, Murat ^a   Aksoy, Sukru ^b   Fotbolcu, Hakan ^c   Duman, Dursun ^d  

^a HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Acibadem Kozyatagi Hospital   (Turkey)

^d ISTANBUL MEDIPOL UNIVERSITY   (Turkey)

Author keywords

Albuminuria; Coronary calcium score; Diabetes mellitus; Inflammatory marker

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INTERLEUKIN 6; NITROGEN; ORAL ANTIDIABETIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UREA; URIC ACID;

ADULT; ALBUMIN BLOOD LEVEL; ALBUMINURIA; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY CALCIUM SCORE; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART INFARCTION; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PREDICTION; PROGNOSIS; SCORING SYSTEM; SUDDEN DEATH; UREA NITROGEN BLOOD LEVEL;

ADULT; ALBUMINURIA; ATHEROSCLEROSIS; BODY MASS INDEX; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR CALCIFICATION;

EID: 84867403414     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.04.012     Document Type: Article

References (29)

1. Anand D.V., Lim E., Lahiri A., Bax J.J. The role of non-invasive imaging in the risk stratification of asymptomatic diabetic subjects. Eur Heart J 2006, 27(8):905-912.
2. Diagnosis and Classification of Diabetes Mellitus American Diabetes Association Standards of medical care in diabetes. Diabetes Care 2009, 32(Suppl. 1):13-61.
3. Diercks G.F.H., van Boven A.J., Hillege H.L., Janssen W.M., Kors T.J.A., de Jong P.E., et al. Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population the PREVEND (Prevention of REnal and Vascular ENdstage Disease) study. Eur Heart J 2000, 21(23):1922-1927.
4. Festa A., Agostino R., Howard G., Mykkanen L., Tracy R.P., Haffners M. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 2000, 58(4):1703-1710.
5. Kwon T.G., Kim K.W., Park H.W., Jeong J.H., Kim K.Y., Bae J.H. Prevalence and significance of carotid plaques in patients with coronary atherosclerosis. Korean Circ J 2009, 39(8):317-321.
6. Freedman B.I., Langefeld C.D., Lohman K.K., Bowden D.W., Carr J.J., Rich S.S., et al. Relationship between albuminuria and cardiovascular disease in type 2 diabetes. J Am Soc Nephrol 2005, 16(7):2156-2161.
7. Bonow R.O. Clinical practice. Should coronary calcium screening be used in cardiovascular prevention strategies?. N Engl J Med 2009, 361(10):990-997.
8. Budoff M.J. Point: diabetic patients and coronary calcium: risk stratification, compliance, and plaque progression. Diabetes Care 2003, 26(2):541-542.
9. American Diabetes Association Diagnosis and classification of diabetes mellitus American Diabetes Association, definition and description of diabetes mellitus. Diabetes Care 2009, 32:62-67.
10. Chen M.L., Hsu C.Y. Should the K/DOQI definition of chronic kidney disease be changed?. Am J Kidney Dis 2003, 42(October (4)):623-625.
11. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990, 15(4):827-832.
12. Fox C.S. Cardiovascular disease risk factors, type 2 diabetes mellitus, and the Framingham Heart Study. Trends Cardiovasc Med 2010, 20(3):90-95.
13. Folsom A.R., Kronmal R.A., Detrano R.C., O'Leary D.H., Bild D.E., Bluemke D.A., et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med 2008, 23:1333-1339.
14. Shaw L.J., Raggi P., Callister T.Q., Berman D.S. Prognostic value of coronary artery calcium screening in asymptomatic smokers and non-smokers. Eur Heart J 2006, 27(8):968-975.
15. Divers J., Wagenknecht L.E., Bowden D.W., Carr J.J., Hightower R.C., Xu J., et al. Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: the African American-Diabetes Heart Study. Diabetes Care 2010, 33(1):131-138.
16. Detrano R., Guerci A.D., Carr J.J., Bild D.E., Burke G., Folsom A.R., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008, 358(13):1336-1345.
17. Mitchell A.R. Coronary calcium screening. N Engl J Med 2009, 361(25):2490-2501.
18. O'Malley P.G., Jones D.L., Feuerstein I.M., Taylor A.J. Lack of correlation between psychological factors and subclinical coronary artery disease. N Engl J Med 2000, 343(18):1298-1304.
19. Blaha M.J., Budoff M.J., DeFilippis A.P., Blankstein R., Rivera J.J., Agatston A., et al. Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet 2011, 20378(9792):684-692.
20. Malik S., Budoff M.J., Katz R., Blumenthal R.S., Bertoni A.G., Nasir K., et al. Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: The Multi-Ethnic Study of Atherosclerosis. Diabetes Care 2011, 34(10):2285-2290.
21. Calberg M.J., Kjøller E. Uric acid as a marker of pathophysiological mechanisms in patients with cardiovascular disease. Ugeskr Laeger 2005, 167(40):3771-3774.
22. Koenig W., Meisinger C. Uric acid, type 2 diabetes, and cardiovascular diseases: fueling the common soil hypothesis?. Clin Chem 2008, 54(2):231-233.
23. Hayden M.R., Tyagi S.C. Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: the urate redox shuttle. Nutr Metab 2004, 191(1):10.
24. Fang J., Alderman M.H. Serum uric acid and cardiovascular mortality the NHANES I Epidemiologic Follow-up Study, 1971-1992. JAMA 2000, 83(May):18. 2004; (Reprinted).
25. Ioachimescu A.G., Brennan D.M., Hoar B.M., Hazen S.L., Byron J.Hoogwerf Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease. A Preventive Cardiology Information System (PreCIS) Database Cohort Study. Arthritis Rheum 2008, 58:623-630.
26. Schiffrin E.L., Lipman M.L., Mann J.F. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007, 116(1):85-97.
27. Bruno G., Merletti F., Biggeri A., Bargero G., Ferrero S., Pagano G., et al. Casale Monferrato Study. Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetologia 2005, 48(3):427-4434.
28. Navarro J.F., Mora C., Gómez M., Muros M., López-Aguilar C., García J. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients. Nephrol Dial Transplant 2008, 23(3):919-926.
29. Saremi A., Anderson R.J., Luo P., Moritz T.E., Schwenke D.C., Allison M., et al. VADT. Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT). Atherosclerosis 2009, 203(2):610-614.